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Abstract.  Ezrin,  previously also known as cytovillin, 
p81, and 80K,  is a cytoplasmic protein enriched in 
microvilli and other cell surface structures.  Ezrin is 
postulated to have a membrane-cytoskeleton linker 
role. Recent findings have also revealed that the NH:- 
terminal  domain of ezrin is associated with the plasma 
membrane and the COOH-terminal domain with the 
cytoskeleton (Algrain,  M., O.  Turunen,  A. Vaheri,  D. 
Louvard, and M.  Arpin.  1993. J.  Cell Biol.  120: 
129-139).  Using bacterially expressed fragments 
of ezrin we now demonstrate that ezrin has an actin- 
binding capability. We used glutathione-S-transferase 
fusion proteins of truncated ezrin in affinity chroma- 
tography to bind actin from the cell extract or purified 
rabbit muscle actin.  We detected a binding site for 
filamentous actin that was localized to the COOH- 
terminal  34 amino acids of ezrin.  No binding of 
monomeric actin was detected in the assay.  The region 
corresponding to the COOH-terminal actin-binding 
site in ezrin is highly conserved in moesin, actin- 
capping protein radixin and EM10 protein of E.  mul- 
tilocularis, but not in merlin/schwannomin.  Conse- 
quently, this site is a potential actin-binding  site also 
in the other members of the protein family.  Further- 
more, the actin-binding  site in ezrin shows sequence 
homology to the actin-binding  site in the COOH ter- 
minus of the B subunit of the actin-capping protein 
CapZ and one of the potential actin-binding  sites in 
myosin heavy chain.  The actin-binding capability of 
ezrin supports its proposed role as a membrane- 
cytoskeleton linker. 
T 
HE  ezrin  protein  family  (also  called  ERM  family; 
Sato et al.,  1992) has potentially an important role 
at the cortical cytoskeleton and may participate  in the 
regulation  of several cellular functions  (see a recent review 
by Arpin et al., 1994). Indirect evidence shows that members 
of the ezrin  protein  family interact  with membranes  and 
cytoskeleton, but more data are needed on the components 
binding directly to ezrin and other proteins of the family and 
how these associations are regulated.  Here our focus is on 
the cytoskeletal interactions  of ezrin,  the prototype protein 
of the family. 
Ezrin is a widely distributed protein located in microvilli 
and other cell surface structures (Bretscher,  1983; Gould et 
al.,  1986;  Pakkanen  et al.,  1987; 1988;  Pakkanen,  1988; 
Hanzel et al.,  1989; Berryman et al.  1993; Franck et al., 
1993).  Based on the homologies in amino acid sequence 
(Turunen  et  al.,  1989;  Gould  et  al.,  1989)  with  other 
cytoskeletal proteins,  it has been suggested that ezrin links 
the cytoskeleton to the plasma membrane. The NH2-termi- 
hal domain of ezrin (200-300 amino acids;  see Fig.  1, do- 
main EzN) shows 37 % identity  to erythrocyte protein band 
4.1 (Conboy et al., 1986) and 23 % identity to talin (Rees et 
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al.,  1990). Both protein 4.1 and talin are linker proteins at 
the cortical cytoskeleton. The NH2-terminal domain of pro- 
tein 4.1 has been shown to be responsible for the binding to 
membrane proteins and the central  10-kD domain to spectrin 
(for reviews see Bennett,  1989; Bretscher,  1991; Luna and 
Hitt,  1992). A similar  functional  structure of ezrin has ap- 
peared when the domains of ezrin have been expressed in 
cells.  Accordingly,  in  ezrin  the  NH2-terminal  domain  is 
localized  to membranes and the COOH-terminal part con- 
talning the a-helical domain colocalizes with actin filaments 
(Algrain  et al.,  1993). Further evidence for the association 
of ezrin with cytoskeleton comes from several reports that 
ezrin is associated with the cytoskeleton in cell fractionation 
experiments,  in which ezrin has been found in the detergent- 
insoluble fraction  containing  the cytoskeleton (Bretscher, 
1983; Hanzel et al.,  1991; Egerton et al.,  1992; Algrain  et 
al., 1993). No specific binding ligand in the membranes or 
in the cytoskeleton has been reported thus far for ezrin. 
Recently, several proteins have been identified  that share 
a strikingly high identity to ezrin. Radixin (Funayama et al., 
1991), moesin (Lankes and Furtlunayr, 1991), merlin/schwan- 
nomin  (Rouleau  et al.,  1993;  Trofatter  et al.,  1993),  and 
EM10 protein ofEchinococcus multilocularis (Frosch et al., 
1991) are 75, 73, 48, and 43 % identical to ezrin, respectively. 
Although  it is possible that the whole ezrin protein family 
functions  as a membrane-cytoskeleton linker,  only radixin 
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al., 1989). Extensive attempts using sedimentation, affinity- 
chromatographic and overlay  assays to show direct interac- 
tion of ezrin with actin or other proteins have been unsuc- 
cessful  (Bretscher,  1983;  1991;  Krieg  and  Hunter,  1992; 
Fazioli et al., 1993). A weak interaction of ezrin with actin 
was detected in sedimentation assays, but the binding was not 
seen in physiological salt concentrations  (Bretscher,  1983, 
1991).  A direct binding of ezrin to the closely related moesin 
has been detected recently by immtmoprecipitation and over- 
lay assays (Gary and Bretscher,  1993), but the physiological 
meaning of this association is not yet known. 
Using bacterially expressed truncated  ezrin constructs we 
now demonstrate that actin in cell extracts and purified mus- 
cle actin bind to ezrin. In our procedure we expressed over- 
lapping parts of ezrin as fusion proteins with glutathione-S- 
transferase  (GST) ~.  Ezrin  fusion  proteins  were  used  in 
affinity  chromatography to identify proteins binding to ez- 
rin. Actin was the only major protein that could be shown 
to bind to ezrin. 
Materials and Methods 
Antisera 
Polyclonal antibody I: a polyclonal  rabbit antiserum raised against human 
ezrin (cytovillin) was described by Pakkanen (1988). We also raised mono- 
clonal antibodies against human ezrin using the COOH-terminal part of ez- 
rin in immunizins mice (Turunen, O.,  T. Wahlstrtm, O. Carl~n, E.-M. 
Salonen, and A. Vaheri, manuscript in preparation). The amino acid region 
362-585 was cloned as a Pst I fragment pCV1 clone (Turunen et al., 1989) 
to pEXI vector for the expression in bacteria. One of  the resulting monoclo- 
hal antibodies (CVP1) was used in characterization of the GST-ezrin fusion 
proteins expressed  from pGEX vectors.  Folyclonal antibody II: rabbit an- 
tiserum raised against human ezrin was a kind gift from Dr. A. Bretscher 
(Coruell University,  Ithaca, NY). The monoclonal mouse anti-ezrin anti- 
body 7_,036, raised against a synthetic peptide comprising the region 575- 
585 of human ezrin, was purchased from Zymed Labs.  (San Francisco, 
CA), the monoclonal antibodies to actin from Sigma Chem. Co. (St. Louis, 
MO),  and the monoclonal antibodies to /5-galactosidase  from Promega 
(Madison, WI). 
Creation and Expression of Truncated Fusion Proteins 
A series of truncated ezrin-fusion proteins (see Fig.  1) were expressed  as 
GST fusion proteins from pGEX vectors (Pbarmacia, Uppsala, Sweden). 
Subclones of the COOH-terminal part of ezrin were produced by PCR using 
ezrin cDNA clone pCV6 (Turunen et al.,  1989) as the template.  Barn H1 
sites were constructed at both ends of the PCR clones for the subcloning 
in the pGEX-3X expression vector.  The NH2-terminal  fusion protein FP 
1-308 was created by subcloning the pCV6 insert to the pGEX-1XT vector 
and removing the DNA fragment Sma I-Nru I (cuts at pCV6 bases 1003 
and 2049, respectively).  The starting site for the protein coding of ezrin was 
regarded as the same as that reported by Gould et al. (1989) and Franck et 
al. (1993). The FP 1-308 fusion protein contained 26 additional amino acids 
coming from the 5'-noncoding region of the pC"¢6 clone.  FP 243-585  was 
created by expressing  the ezrin pLAt1 clone (containing amino acids 243- 
585) with EcoRI sites at the ends of the clone (Turunen et al., 1989) in the 
pGEX-lhT vector. The clones ending in the ezrin residue 585 used the stop 
codon of ezrin eDNA. The stop codon for the clone FP 1-308 was formed 
from the non-coding region of ezrin cDNA, thus adding 15 amino acids to 
the carboxy terminus of FP  1-308 protein: AIILESPPVLCWEQD.  The 
clones FP 279-485,  FP 279-531,  and EP 477-579 used the stop codons of 
the pGEX vector; consequently they all contained 6-15 COOH-terminal 
amino acids expressed from the vector (the additional amino acids at the 
COOH terminus ofezrin were: FP 279-485, DPREFIVTD; FP 279-531 and 
FP 477-531, RIPGNSS; FP 477-579,  GSPGIHRD). The correct sequence 
of the clone FP 552-585 was confirmed by sequencing with Sequenase 2.0 
1. Abbreviations used in this paper:  GST, glutathione-S-transferase. 
(Un. States Biochemicals,  Cleveland, OH). The correct expression of all 
clones except FP 1-308 was confirmed by a positive reaction with antibodies 
specific to ezrin. 
The  fusion proteins were produced and purified using basically the 
method of Smith and Johnson (1988). Escherichia coli DH5 cells were used 
as the host in protein expression.  The synthesis of the fusion proteins was 
induced by incubating the bacteria with 1.0 mM isopropyl/5-v-thiogalacto- 
pyranoside (IPTG) for 1-5 h at 30°C. The cells were sedimented by centrifu- 
gation and the cell pellet was then solubilized in buffer A (10 mM phosphate 
buffer  pH  7.4/0.165  M  NaCI/1.0  mM  MgCI2/0.2  mM  ATP/0.2  mM 
DTT/I% Triton X-100/1.0 mM PMSF). After sonication, the cell debris was 
removed by centrifugation (10,000 g,  10 min) and the supernatant was 
filtered through a MilLipore 0.45 ~tm filter. The supernatant was applied to 
Glutathione-Sepharose  4B beads (Pharmacia) to purify the fusion proteins. 
Glutathione-Sepharose  4B beads were washed with buffer A before incu- 
bation with bacterial lysate. The fusion proteins were bound from bacterial 
lysate to Glutathione-Sepharose beads by incubating for a minimum of 10 
rain  with  end-over  shaking  at  room  temperature.  The  Glutathione- 
Sepbarose beads containing the fusion protein were washed with buffer A 
to remove unbound bacterial proteins. 
Since the fusion protein FP 1-308 was insoluble in E.  coli cells, it was 
purified by preparative SDS-PAGE.  After staining with ice-cold  0.9 M 
potassium acetate, the corresponding gel slice was cut out from the gel and 
the protein was electroeluted from the gel slice in a buffer containing 100 
raM glycine and 30 raM Tris/HCl pH 8.0. After dialysis against buffer A, 
the FP 1-308 protein was purified by Giutathione-Sepharose 4B beads. 
Preparation of  psS]Methionine-labeled Cell Lysate 
and Incubation with GST-Ezrin-Sepharose Beads 
JEG-3 choriocarcinoma cells (Amer.  Type Culture Collection, Rockville, 
MD; HTB 36) were labeled overnight with [35S]methionine (30 #Ci/ml) in 
methionine-frec MEM supplemented with 2 % FCS. The cells were washed 
with PBS and collected on ice in buffer A. After sonication, the cell debris 
was removed by centrifugation at 10,000 g (10 rain) and the cell lysate was 
filtered through a Millipore 0.45 ~tm filter. 
The cell lysate was incubated for a minimum of 15 rain with GST-ezrin- 
Sepharose beads using shaking at room temperature. In the binding experi- 
ments '~5-50/d of 50% Sepharose  slurry containing ,,ol-20 ~g of fusion 
protein was incubated with cell extract obtained from a third to fifth part 
of a confluent 100-mm Petri dish. The total volume in the binding experi- 
ment was 0.5-1.0 nil. Before analyzing the proteins bound to GST-ezrin- 
Sepharose beads, unbound proteins were removed by washing several times 
with  buffer  A,  more  than  ten  times  the  bed  volume.  The  GST-ezrin 
Sepharose  beads containing the bound cellular material and the control 
GST-Sepharose  beads were applied directly in SDS-PAGE. 
Effect of  NaCl and SDS on the Binding of  Actin 
to GST-Ezrin 
The effect of NaCl on binding of [35S]methionine-labeled cellular actin to 
ezrin is shown for FP 477-585. Concentrations  of NaC1 were varied in buffer 
A: 0.15, 0.5, 0.8, and 1.0 M. The binding of actin to GST-ezrin-Sepharose 
beads and the washing of the beads after binding were accomplished in the 
corresponding NaCl concentration. We also tested the binding of actin to 
GST-ezrin fusion proteins in the low salt concentration of buffer B (10 mM 
phosphate buffer  pH 7.4/0.2  mM CaCl2/0.2  mM ATP/0.2  mM DTT/I% 
Triton X-100/I.0 mM PMSF). The sodium concentration in buffer B was 
10 raM. For the monomer binding assay, [35S]methionine-labeled JEG-3 
cells were washed with PBS, and then rapidly once with buffer B without 
detergent.  The cells were directly suspended in buffer B and prepared for 
the binding assay as described above.  The binding of actin to GST-ezrin 
was also tested with 0.01% and 0.1% SDS added to binding experiment in 
buffer A. 
Binding of  Purified Muscle Actin to GST-Ezrin 
Rabbit skeletal  muscle actin was  prepared according to the method of 
Spudich and Watt (1971). Purified actin (2/~g as a single band in SDS- 
PAGE) was  stored on ice in G-buffer  (2 mM Tris-HC1 pH 7.5/0.2  mM 
CAC12/0.2 mM ATP/0.5 mM ~-mercaptoethanol). Actin was polymerized 
during 30 min in buffer A (without PMSF) and incubated at the concentra- 
tion of 1.0 mg/ml for 30 rain in buffer A (without PMSF) with FP 243-585 
Sepharose 4B beads or GST-Sepharose 4B beads in a total volume of 200 
f,l. The concentration of FP 243-585 was ,,040 ttg/ml. As a negative control 
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GST was located on the NH2-terminal side of the fusion proteins. 
Figure 1. Summary of the lo- 
calization of the actin-binding 
site in ezrin and the regions of 
the protein detected by differ- 
ent antibodies  raised  against 
human ezrin.  Abbreviations: 
domains of ezrin are indicated 
by EzN, Ezc~ and EzC;  , 
regions of ezrin expressed as 
GST-fusion  proteins;  poly- 
clonal Ab I denotes the anti- 
body raised  against ezrin  in 
our  laboratory;  polyclonal 
Ab  II  denotes  the  antibody 
raised  by Dr.  A.  Bretscher; 
nd,  not determined.  The ac- 
tin-binding  COOH-terminal 
be phosphorylated are shown. 
we used the GST-Sepharose 413 beads at the GST concentration of ",200 
#g/ml. After washing several times by the binding buffer the beads were 
analyzed in SDS-PAGE.  It was important to polymerize the actin before 
adding to  GST-ezrin-Sepharose beads  or  control  GST-Sepharose beads. 
Otherwise actin was polymerized inside the porous structures of Sepharose 
beads and consequently remained bound to the beads. 
Binding of purified muscle actin was tested also in monomer actin buffer 
conditions (buffer B) in actin concentration of 1.0 mg/ml. We used both fila- 
ment free G-actin and a G-actin preparation containing actin filaments: after 
polymerization with 150 mM KCI and 1.0 mM MgC12, the actin was dia- 
lyzed two days against G-buffer and was not ultracentrifugated to remove 
the remaining filaments. 
Analysis of Proteins Bound to 
GST-Ezrin-Sepharose Beads 
SDS-PAGE  was  used to  identify  the proteins bound to  the GST-ezrin- 
Sepharose beads. The proteins in the gel were detected by autoradiography 
or  by  immunoblotting with  monoclonal actin  antibody  in a  dilution of 
1"2,500.  An estimation of the amounts of fusion proteins in the binding ex- 
periments was obtained by staining the immunoblot filter with 0.2% Pon- 
ceau red in 3% TCA or by Coomassie blue staining of the gels. The binding 
of purified muscle actin to FP 243-585 Sepharose beads was detected by 
Coomassie blue staining of the SDS-PAGE gel or by immunoblotting with 
actin antibody. 
Results 
General Strategy to Detect Proteins Interacting 
with Ezrin 
We have here used affinity chromatography to identify pro- 
teins binding to ezrin. The truncated forms of ezrin were ex- 
pressed as fusion proteins with GST in pGEX expression 
system  (Smith and  Johnson,  1988).  GST fusion proteins 
were purified by using the affinity of GST to glutathione cou- 
pled to Sepharose 4B beads. We used GST-ezrin fusion pro- 
teins  immobilized on Glutathione-Sepharose 4B beads  in 
affinity chromatography to detect which proteins in cell ly- 
sate bind to GST-ezrin ("GST-ezrin" is used to refer to all the 
different truncated ezrin clones created as fusion proteins 
with GST). The advantages of  this method are that no chemi- 
cal  coupling reagents are used and the orientation of the 
GST-ezrin on the Sepharose beads is known. While the fu- 
sion protein is bound to the Sepharose beads by the GST- 
part, the COOH terminus of  ezrin is uniformly oriented away 
from the matrix and is free to interact with other proteins. 
Analysis of the Bacterial Expression Products 
A  series  of truncated GST-ezrin fusion proteins  (Fig.  1) 
covering the whole coding sequence of ezrin was  created 
from ezrin eDNA.  Full-length GST-ezrin could not, how- 
ever, be purified for the actin-binding assay since the expres- 
sion level was very low and the fusion protein was insoluble. 
To see whether the fusion proteins were fully expressed, the 
observed sizes in SDS-PAGE were compared to the sizes cal- 
culated on the basis of sequence data. The theoretical sizes 
of the truncated expression products of ezrin were added to 
the size of GST protein (27 kD). The observed sizes in SDS- 
PAGE compared to expected values (in parenthesis) were as 
follows: FP 1-308, 67 kD (65 kD); FP 243-585, 80 kD (68 
kD); FP 279-531, 71 kD (58 kD); FP 279-485, 59 kD (53 
kD); FP 47%585, 42 kD (40 kD); FP 47%531, 37 kD (34 kD); 
FP 47%579, 42 kD (40 kD); FP 507-585,  35 kD (37 kD); 
FP 552-585, 31 kD (31 kD). The comparison of  the observed 
and estimated sizes indicated that all fusion proteins were ex- 
pressed in full length. All the GST-ezrin fusion proteins were 
expressed close to the expected sizes, except the clones con- 
raining the heptaproline region (FP 243-585, FP 279-485, 
FP 279-531; Fig.  1). Their observed sizes were ,,o6-13  kD 
higher than the calculated values. 
Several antibodies raised against ezrin were used in immu- 
noblotting to confirm the correct expression of the truncated 
fusion proteins (Fig. 2). All the GST-ezrjn fusion proteins, 
except FP 1-308, were detected by one or more of the ezrin 
antibodies. The immunoblotting analyses also identified the 
location of the  sites detected by different antibodies.  The 
polyclonal antibody I (PAb I) raised against the full-length 
cellular ezrin reacted predominantly with the region contain- 
ing the predicted a-helical domain Ez, and the heptaproline 
sequence (Fig. 2, lanes 3 and 4). The reaction was weaker 
against the COOH-terminal domain EzC (Fig. 2, lanes 6-8) 
and PAb I did not react at all with the NH2-terminal domain 
EzN (Fig. 2, Lane/). The polyclonal ezrin antibodies pre- 
pared by Dr. A. Bretscher (PAb ID gave a similar staining 
pattern except that they reacted with the COOH-terminal 
epitopes stronger than PAb I (Fig. 2, lanes 5-8) and detected 
a larger COOH-terminal region. As a result, PAb II detected 
the region 47%531  and possibly also the region 552-585, 
while PAb I did not detect the regions 47%531 and 552-585 
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(A) A 45-kD protein was bound to the FP 243-585 fusion protein 
(lane 1) and FP 477-585 fusion protein 0ane 2) immobilized on 
Glutathione-Sepharose 4B  beads  when  cell  lysate  from JEG-3 
choriocarcinoma cells labeled with l~SS]methionine  was incubated 
with GST-ezrin-Sepharose beads. The 45-kD protein did not bind 
to FP 477-579 Sepharose beads (lane 3). In this experiment the 
Triton-X-100 was omitted from the buffer A. The proteins bound 
to GST-ezrin-Sepharose beads were detected using autoradiogra- 
phy. (B) The 45-kD protein bound to GST-ezrin-Sepharose beads 
was identified in immtmoblotting using a monoelonal antibody to 
actin in a dilution of 1:2,500. The immunoblot shows the aetin- 
binding experiments using GST-protein (lane 1), FP 243-585 fu- 
sion protein (lane 2), and FP 477-585 fusion protein (lane 3) im- 
mobilized on Glutathione-Sepharose 4B beads. As antibody control 
the material bound to FP 243-585 Sepharose beads was stained 
with  monoclonal  antibody  to  15-galaetosidase in  a  dilution  of 
1:2,500 (lane 4). 
Figure 2. Immunoblotting of the GST-ezrin  fusion proteins. The E. 
coli bacterial pellet was solubilized in Laemmli's sample buffer and 
immunoblotted using polyclonal antibody I (PAb  I) in a dilution of 
1:2,000, polyclonal antibody II (PAb//) in a dilution of 1:2,000, 
monoclonal antibody CVP1 in a dilution of 1:2,000, and monoclo- 
nal antibody Z036 in a dilution of 1:5,000. 
(Fig. 2, lanes 5 and 9, respectively). The epitope detected 
by monoclonal antibody CVP1 is located at the site 532-558, 
since it detected FP 477-579 (Fig. 2, lane 8) and FP 477-558 
(not shown), but not FP 279-531  and FP 477-531  (Fig. 2, 
lanes 3 and 5, respectively). CVP1 is specific to human ezrin 
(our unpublished data). Since the only differences between 
mouse and human ezrins in the region 532-558 or close to 
it are at the sites Val-531 (Leu-532 in mouse ezrin) and Ser- 
535 (Ash-536 in mouse ezrin) (see Fig. 8`4), the epitope rec- 
ognized by CVP1 is concluded to include residue 531 and/or 
residue 535. The monoclonal antibody Z036 is raised by Dr. 
A. Bretscher against a synthetic peptide comprising the re- 
gion 575-585. Immunoblotting with Z036 showed that all the 
fusion proteins ending in the COOH terminus (FP 243-585, 
FP 477-585, FP 507-585,  and FP 552-585) contained an in- 
tact epitope detected by the Z036 monoclonal antibody. 
Binding of  Actin to GST-Ezrin-Sepharose 4B Beads 
The major protein binding to GST-ezrin-Sepharose  4B beads 
from  [35S]methionine-labeled JEG-3  choriocarcinoma cell 
lysate in buffer A had the size of 45 kD in SDS-PAGE (Fig. 
3 ,4, lanes I  and 2). There were also some unidentified pro- 
teins (molecular mass region 70-200 kD) binding in very 
low amounts to the Eza domain (FP 243-585; Fig. 3 A, lane 
/) but not to the EzC domain (FP 477-585; Fig. 3 A, lane 
2). In immunoblotting, the 45-kD protein binding to FP 243- 
585 and FP 47%585 Sepharose beads was found to be actin 
(Fig. 3 B, lanes 2 and 3, respectively) and had the same size 
as cellular actin (not shown). As antibody control, the cellu- 
lar material bound to FP 243-585 Sepharose beads (Fig. 3 
B, lane 4) was stained with monoclonal antibody to/3-galac- 
tosidase. Actin did not bind to the GST-Sepharose control 
beads (Fig. 3 B, lane/). Occasionally very weak binding to 
control beads was observed, but the amount of binding was 
insignificant (an example is seen in Fig. 4, lane 8) when com- 
pared to the specific actin binding. 
In our actin-binding assay we normally used  1% Triton 
X-100.  However, actin was bound to truncated ezrin simi- 
larly in the absence (Fig.  3 A, lanes 1 and 2) or presence 
(Fig. 4, lane 4) of the nonionic detergent. The independence 
of the use of the nonionic detergent Triton X-100 indicates 
that hydrophobic interactions do not have a major role in the 
binding of actin to GST-ezrin. 
To see whether ezrin binds also to monomeric actin, we 
tested the binding of actin to GST-ezrin in the low salt buffer 
(buffer B) that keeps the actin in monomeric form. In this 
experiment the actin in  [asS]methionine-labeled cell lysate 
did not bind to GST-ezrin (FP 243-585 and FP 477-585) in 
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the COOH-terminal domain of ezrin (FP 47%585). [35S]Methio- 
nine-labeled JEG-3 cell extract was used as the source for actin. 
When JEG-3 ceils were solubilized in buffer B (G-buffer), actin did 
not bind to FP 243-585 Sepharose beads (lane 2) or FP 477-585 
Sepharose beads (lane 3). Lane 1 shows the GST control experi- 
ment in buffer B. In lanes 4-7the influence of  higher concentrations 
of NaCI were  tested  on the  actin binding  of FP 477-585. The 
[35S]methionine-labeled JEG-3 cell lysate was prepared in buffer 
A containing 0.165 M NaC1 (lane 4), 0.5 M NaCI (lane 5), 0.8 M 
NaCI (lane 6), and 1.0 M NaCI (lane 7). Lane 8 shows the experi- 
ment with GST-Sepharose control beads in 0.165 M NaC1. The 
influence of SDS on the actin binding of FP 477-585 was tested in 
buffer A with 0.01% SDS (lane 9) or 0.1% SDS (lane 10). 
10  mM  sodium phosphate buffer (Fig.  4,  lanes  2  and  3, 
respectively). This shows that monomeric actin did not bind 
to GST-ezrin (region 243-585).  The negative result in the 
low salt buffer was not due to the absence of actin in the cell 
lysate made in buffer B, as confirmed by immunoblotting 
(not shown). 
The GST-ezrin fusion proteins could be easily eluted by 
15 mM glutathione from the Glutathione-Sepharose beads 
except the fusion protein FP 243-585. However, we could not 
use  the  glutathione  elution  to  test  whether  actin  binds 
specifically  to  GST-ezrin,  since  the  actin  was  partially 
washed away from the beads also with the buffer only (not 
shown). Probably the washings broke the actin filaments on 
the beads, but also a potentially low affinity binding of actin 
to GST-ezrin could explain the elution of actin by binding 
buffer (buffer A). 
In the experiments with  [35S]methionlne-labeled cell ly- 
sate,  a  few proteins were binding in small amounts (com- 
pared to actin) to GST-ezrin-Sepharose beads, but not to the 
GST-Sepharose control beads. An example is a 36-kD pro- 
tein that bound to the GST-ezrin-Sepharose beads (Fig. 3 A, 
lanes 1 and 2; Fig. 4, lane 4) but not to the control beads 
(Fig. 3 A, lane 3; Fig. 4, lane 8). However, a concentration 
of 0.5-1.0 M  NaCl in the binding buffer (Fig. 4, lanes 5-7) 
or 0.1% SDS (Fig. 4, lane 10) removed the minor proteins; 
an upper minor protein appearing in high salt experiments 
(Fig.  4,  lanes  5-7)  was  occasionally  detected.  Concen- 
trations of 0.5-1.0  M  NaCl  or 0.1%  SDS did not prevent 
the  binding  of GST-ezrin fusion  protein  to  Glutathione- 
Sepharose beads as assayed by Coomassie blue staining of 
Figure 5.  Binding of purified  rabbit  muscle actin to GST-ezrin 
Sepharose beads.  F-actin was incubated in buffer A with GST- 
Sepharose beads (lane 1) and FP 243-585 Sepharose beads (lane 
2). Lanes 1 and 2 shows Coomassie blue staining of the Sepharose 
beads after the actin-binding experiment. Lane 3 shows the binding 
of  actin filaments in buffer B to FP 243-585. Lane 4 shows the bind- 
ing experiment of filament-free monomeric actin in buffer B with 
FP 243-585 Sepharose beads. The actin-binding in lanes 3 and 4 
was detected by immunoblotting with an actin monoclonal antibody 
in a dilution of 1:2,500. 
SDS-PAGE gels (not shown). These results show that the mi- 
nor binding proteins do not mediate the binding of filament 
actin to GST-ezrin. They also show that the EzC domain 
binds only actin. 
With  increasing  salt  less  actin  bound  to  FP  477-585 
Sepharose beads (Fig. 4, lanes 4-7). This can be explained 
by the short filaments which do not bind in the lower NaCl 
concentrations (0.5 M) while long filaments can bind to the 
GST-ezrin-Sepharose beads even in 1.0 M Natl. Most of the 
binding was lost in 0.5 M NaCl indicating that the actin bind- 
ing of ezrin is mediated mainly by electrostatic interactions. 
Also the GST-ezrin fusion protein FP 243-585 had the same 
binding profile (not shown). 
The  GST-ezrin fusion  proteins  containing  the  COOH- 
terminal region of ezrin were partially degraded during the 
bacterial growth or purification of the fusion proteins. The 
use of proteinase inhibitors did not eliminate the degrada- 
tion. The short incubation and centrifugation times during 
the purification were essential to reduce the degradation. In 
Fig.  2  (lanes  2-8),  the  lower minor  bands  are  probably 
degradation products, since they were stained by antibodies 
to ezrin. The negative staining of the degradation products 
with the monoclonal antibody Z036 (detecting the region 
575-585) shows that the degradation products of the fusion 
proteins FP 243-585, FP 507-585,  FP 477-585, and FP 552- 
585 (Fig. 2, lanes 2, 6, 7, and 9, respectively) seen in immu- 
noblotting lack the COOH terminus of ezrin. The negative 
actin-binding result with the COOH-terminal domain where 
six amino acids were omitted from the COOH terminus (Fig. 
3 A, lane 3 and FP 477-579 in Fig. 6) shows that the possible 
degradation  products  are  not  responsible  for  the  actin 
binding. 
We also used purified rabbit muscle actin to demonstrate 
the direct binding of actin to ezrin. While the GST-Sepharose 
control beads did not bind purified rabbit muscle F-actin 
(Fig.  5,  lane  /),  the  F-actin  was  bound  to  FP  243-585 
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onine-labeled JEG-3 cell lysate was used in the actin-binding ex- 
periments done in buffer A: The actin binding with different GST- 
ezrin-Sepharose beads and GST-Sepharose beads was detected by 
autoradiography. The strong low molecular mass band in lane FP 
1-308 is background binding. 
Sepharose beads in the same way as the actin from cell ly- 
sates (Fig. 5, lane 2). Lanes 1 and 2 in Fig. 5 show Coomas- 
sic blue staining of  the binding results. Although the concen- 
tration of purified actin in the binding experiments was in 
general  1.0 mg/ml, the binding of F-actin to FP 243-585 
Sepharose beads could be detected easily in actin concentra- 
tions less than 0.1 mg/ml (not shown). The results with the 
highly  purified  proteins  confirm  that  filamentous  actin 
bound directly to GST-ezrin and that for the binding no addi- 
tional protein factors were needed. 
Furthermore, we obtained evidence that the F-actin bound 
to GST-ezrin also in low salt concentration (buffer B). When 
the G-actin solution was not free from the actin filaments we 
could see a clear binding to GST-ezrin (FP 243-585; Fig. 5, 
lane 3). No binding of actin occurred in G-buffer when the 
filaments were removed by centrifugation (180,000 g for 2 h; 
Fig. 5, lane 4). Lanes 3 and 4 in Fig. 5 show immunoblotting 
of the binding results with monoclonal actin antibodies. As 
a conclusion, physiological salt is needed only for the forma- 
tion of actin filaments but not for the binding of ezrin. This 
supports the possibility that ezrin could bind also monomeric 
actin but the affinity may be too low for the binding to be 
detected in affinity chromatography. 
Identification of the Actin-binding Site in Ezrin 
To identify the actin-binding site in ezrin we produced a se- 
ries  of GST-ezrin  fusion proteins  containing overlapping 
parts  of ezrin.  A  summary of the actin-binding results is 
shown in Fig.  1. We observed that all the GST-ezrin fusion 
proteins binding actin contained an intact COOH terminus 
of ezrin.  The NH2-terminal domain (FP  1-308; Fig. 6) as 
well as the predicted a-helical domain (FP 279-531  and FP 
279-485; Fig. 6) did not bind actin in physiological salt con- 
centration.  Already the  omission of six  COOH-terminal 
amino acids of ezrin fully prevented any actin binding (Fig. 
3 A, lane 3; FP 477-579  in Fig. 6). This shows that if other 
parts in ezrin were binding actin the intact COOH terminus 
was needed for the binding to occur. The negative actin bind- 
ing of the fusion proteins FP 279-485 and FP 477-579  was 
confirmed also with the purified muscle F-actin (not shown). 
Since SDS  in the purification of fusion protein FP  1-308 
might affect the binding properties of FP 1-308, it is not fully 
ruled out that EzN could not bind actin in different condi- 
tions. 
The actin-binding capability was confined to a stretch of 
34 amino acids at the COOH terminus of ezrin (FP 552-585; 
Fig. 6). Both actin in cell lysate (Fig. 6) and purified muscle 
actin (not shown) bound to FP 552-585.  The inability of 
different GST-ezrin fusion proteins missing the COOH ter- 
minus of ezrin (FP 1-308, FP 279-531,  FP 279-485,  and FP 
47%579)  to bind actin shows that possible bacterial impuri- 
ties  or  unspecific binding  to  any  fusion protein  are  not 
responsible for the observed actin binding of GST-ezrin. The 
actin binding was specific to a short COOH-terminal region 
in ezrin. Since the COOH terminus of FP 47%579 contains 
a few additional amino acids (GSPGIHRD) expressed from 
the vector, theoretically these amino acids could also prevent 
the actin binding of a site located nearby. Consequently, we 
cannot conclude that the short acidic COOH-terminal region 
(579-585)  would be the site binding to actin. 
Discussion 
The actin binding of ezrin detected in our affinity-chromato- 
graphic assay confirms the earlier suggestions that ezrin has 
a structural role in microvilli and other cell surface struc- 
tures linking the cytoskeleton to the plasma membrane. Our 
results showing that the actin-binding site is located within 
the 34 COOH-terminal amino acids of ezrin confirm the ear- 
lier models of the domain structure of ezrin. The expression 
of truncated ezrins in CV-1 monkey kidney cells had already 
suggested that the actin-binding site is located in the COOH- 
terminal region comprising Ezc~ and EzC domains (Algrain 
et al., 1993).  Since the spectrin/actin-binding site in protein 
4.1  is located in the middle of the protein it has been pro- 
posed that the predicted c~-helical domain in ezrin would be 
responsible for the actin binding (Krieg and Hunter, 1992). 
The limited homology in this region to several cytoskeletal 
proteins gives additional support to this hypothesis (Turunen 
et al.,  1989;  Gould et al.,  1989). 
However, in our experiments we could not find any direct 
actin binding in the Eza domain. A contribution of the Ezc~ 
domain to the actin-binding of ezrin is not ruled out, since 
the Eza domain has 23-28 % identity with tropomyosin or 
~40%  similarity when the identical positions of hydropho- 
bic and charged amino acids are counted in addition. The 
similarity without any  gaps  in  the  sequence  (about  100 
amino acids) covers two pairs out of seven a  and f3 quasi- 
equivalent actin-binding sites in tropomyosin (Parry,  1975; 
McLacMan and Stewart,  1976;  Hitchcock-DeGregori and 
Varnell, 1990).  In addition, the Ezot domain is partially am- 
phipathic with hydrophobic amino acids concentrated at po- 
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lirdschwannomin, and EM10. O,  NH2-terminal domain (amino 
acids 1-300);  m,  predicted a-helical domain; --  proline-rich 
amino acid stretch; ram, COOH-terminal domain (the actin-binding 
site in ezrin and the potential actin-binding sites in other proteins 
are shown in black). Percentage sequence identities are shown in 
comparison to ezrin. 
sitions a  and d  in the repeat of seven amino acids (unpub- 
lished data).  Consequently, the Ezot domain could form a 
tropomyosin-like actin-binding surface. The homologies of 
the  Ezot  domain  to  different  cytoskeletal  proteins,  like 
tropomyosin, myosin, caidesmon, troponin T, and keratins 
(Turunen et al., 1989; Gould et al., 1989) may also indicate 
interactions with several proteins in the cortical cytoskeleton. 
The sequence identities between ezrin, radixin, moesin, 
merlin (also called schwannomin),  and  EM10 protein are 
strongest  in  the  NH2-terminal  domain.  The  identity  be- 
tween ezrin, radixin, and moesin in this region is over 80 %, 
while the average identity of the whole proteins is 75 %. The 
identity between merlin and other members of the protein 
family is 62 % in the NHe-terminal domain and 48 % for the 
whole proteins.  EM10 protein shows 43 % overall identity 
with ezrin and 55 % identity in the NH2-terminai domain. 
The differences appear mostly in the predicted ot-helicai and 
COOH-terminai domains (see Fig. 7). For example, a long 
proline-rich region at the end of the predicted ot-hdical do- 
main is found in ezrin, radixin and merlin, but not in moesin 
and EM10 protein. In addition, the predicted a-helical do- 
main is longer in moesin than in the other proteins. 
The strong similarities in the amino acid sequences and 
similar cellular locations suggest a common role for ezrin 
protein family as membrane-cytoskeleton  linkers. The mem- 
bers of the protein family  -  ezrin, moesin, and radixin- are 
located in various cell surface structures where they colocal- 
ize with actin (Bretscher, 1983; Gould et ai.,  1986; Pakka- 
nen et al., 1987; Pakkanen, 1988; Hanzel et al.,  1989; Tsu- 
kita et al.,  1989; Sato et al.,  1991,  1992; Furthmayr et al., 
1992;  Berryman et al.,  1993;  Franck et al.,  1993).  Also 
EM10  protein has  a  cell  surface location  (Frosch et al., 
1991). The different phosphorylation patterns of ezrin, moe- 
sin, and radixin indicate different ways to regulate each pro- 
tein (Fazioli et al.,  1993; Franck et ai.,  1993). 
The COOH-terminal region of 25 amino acids in ezrin, 
moesin,  radixin,  and  EM10  protein forms the most con- 
served region in the whole COOH-terminal domain (Fig. 8 
A),  as also noted by Lankes et al.  (1993).  Especially, the 
comparison with EM10 sequence shows that the homology 
is centered around the conserved tyrosine (Tyr-564 in ezrin). 
The high degree of sequence homology in this region could 
be indicative of a  common actin-binding site. Only radixin 
has been reported to bind actin (Tsukita et al., 1989), but no 
data on a  specific actin-binding site are yet available. 
The  COOH-terminal  sequence  of merlin/schwannomin 
does not show any remarkable homology to the actin-binding 
site of ezrin and does not have the conserved tyrosine (see 
Fig. 7 A). The cellular location of merlin/schwannomin, the 
tumor suppressor for neurofibromatosis 2  (Rouleau et ai., 
1993; Trofatter et al.,  1993), has not yet been reported. It 
will be interesting to see whether merlin/schwannomin can 
A 
h-ezrin  478 VYEpVSY~VQESI.QD~-SAELSSE~IRDDRNEIKRI~VQRQLVI7-SSELSQ~T~qDIINh~q4-RCC~D~I~X1k~T~D~T.  585 
m-ezrin  477  .....  N  .....  O  ...........  -  .........  L  ......................  L...N  ......................  -  ...........................  M  586 
m-radixin  477  I~TI.PT  ....  .NH4..QD.NSAEA  ........  VMhU.S..~qv..TQ  .....  KK..~ .....  A  .....  T.K.Q..VL.A..V-KA  .................  HA  ......  M  583 
h-moesin  473  .A..A  .....  .NE...QD.NC.AEA..D.RADAMAK..S..E.T  ..........  KH.KA.T...AN  ....  S.K.A..M..A...-.L  ........................  SM 577 
E.III/I-I~0  450  ~KS.VNGS~[~SQDDESE.KELEVI~NVR.T..S.V.AVS...TL.q~<.AN.KM..~ST..QS.b~DI.RR.EY.V-.E.N  .......  N..K...MC.V~..SM 559 
h-merlin  486  PIPAPLPPDIP.FhLI.DSLSFD-~-I.KEKVEYM..SKHL.E..NE.KT.IF_AI/<I/<ERE.AL..L  ....  SD.G.SS.~.IKKLqIQSA.S.VAF..E. 595 
B 
h-ezrin  502  LSS~ZRDDRNEEK-RZTEAHKNERvQRQLVTLS~EL~QARDENKRTHNDIIHNENMRQGRDKYKTLRQIRQ3NTKQRIDEFEAL  585 
c-capZ  190  LTRQMEKD~tTVS~SS-P~IANIGRLvEDMEN~I~TLNEIYFGKTKDIV~GLRSIDAIPD~QKYKQLQRE~SQV~T~RQIYIQP~  277 
h-ca-mhc  697  GVL~ZRICKKGFPNRILYGDF  ......................................  RQRYRILNPA-AIPEGQFIDSRKGA  742 
h-sk-mhc  698  GVLIK~IRICRKGFPNRXLYGDF  ......................................  KQRYRVLNAS-AILEGQFIDSKKAC  743 
c-BBMI  571  G  LMI~VRVRRAGYAF  RQ  LYQP  F  ......................................  L~YKMLSRK  -  TWPRWTGG DR  EGAE  616 
h-nm-mhc  696  CVLI~XRICRQGFPNRVVFQBF  ......................................  RQRYEILTPN-SIPKGFMDGKQACV  741 
Figure 8. (A) Comparison of the COOH-terminal domains in the ezrin family of proteins. The actin-binding site in human ezrin is under- 
lined. Identical residues and gaps are indicated by dots and dashes, respectively. Databank sources for the different proteins: human ezrin 
(P15311 or P23714), mouse ezrin ($66825), mouse radixin ($66820), human moesin (M69066), human merlin (L11353), and Echinococcus 
multilocularis protein EM10 (M61186). (B) Actin-binding regions in chicken CapZ/~ subunit (P14315) and myosin heavy chain (mhc) 
sequences are compared to similar sequence motifs in human ezrin (P15311 or P23714). The aligned myosin heavy chains were selected 
to represent different grades of identity to the KYKXL motif in ezrin. The sequences of the myosin heavy chains were obtained by BLAST 
network service of NCBI. Abbreviations and databank sources for the myosin heavy chains: h-ca-mhc, human cardiac muscle (P12883); 
h-sk-mhc, human embryonic fast skeletal muscle (P11055); c-BBMI, chicken brush border myosin I (A33620); h-nm-mhc, human nonmus- 
cle (M81105). Identities and identical charges in comparison to human ezrin are indicated in bold.  Dashes indicate gaps. 
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terminus some amino acids essential for the actin-binding. 
A new feature of merlin/sehwarmomin is the finding of alter- 
native splicing transcripts affecting the COOH terminus of 
the protein (Arakawa et al., 1994; Haase et al., 1994; Hara 
et al.,  1994;  Pykett et al.,  1994).  The alternative splicing 
could change or even regulate the binding properties of merlin/ 
schwannomin. 
The  region  558-578  in  ezrin,  (see  Fig.  8  B)  moesin, 
radixin, and EM10 protein shows high sequence homology 
also with a potential actin-binding site in the myosin heavy 
chain (Keane et al., 1990; Vandekerckhove and Vancomper- 
nolle,  1992)  and the actin-binding site of CapZ/3 subunit 
(Hug et al., 1992). Especially, the KYKXL motif  ("K" refers 
here to both K and R) is found in skeletal and cardiac myosin 
heavy chains, brush border myosin I (a microvillus protein), 
CapZ/3 subunit and the ezrin protein family, except merlin/ 
schwannomin. In myosin heavy chains the KYKXL motif is 
located in the middle of the protein in the S1 head domain, 
but does not belong to the major actin-binding sites observed 
in  the  crystallographic  studies  (Rayment  et  al.,  1993; 
Schrtder et al.,  1993).  Furthermore, the KYKXL motif is 
not fully conserved in all myosins (see Fig. 8 B). Although 
the peptide made from this site binds actin (Keane et al., 
1990), the importance of the site for the actin binding in my- 
osins is not clear. In CapZ/3 subunit the actin-binding site 
is localized in a short COOH-terminal region like in ezrin. 
In addition,  the distance of the KYKXL motif from the 
COOH terminus differs in CapZ/3 subunit only by one amino 
acid from that in ezrin. 
CapZ and radixin are reported to be barbed end-capping 
proteins (Casella et al., 1987; Tsukita et al.,  1989) and be- 
longs to class II actin-capping proteins that do not sever actin 
(for review see Weeds and Maciver,  1993).  Although the 
actin-capping activity is not fully ruled out, the immunoelec- 
tron microscopical observations (Pakkanen et al., 1987; Ber- 
ryman et al., 1993) implicate lateral binding of ezrin to actin 
filaments to be a major form of interaction of ezrin with actin 
in microvilli. In this respect ezrin has a similar location in 
microvilli as brush border myosin I  (for reviews  see Lou- 
vard,  1989;  Bretscher,  1991). 
The actin-binding site at the COOH terminus of ezrin is 
a strongly basic region (amino acids 558-578)  ending in a 
short stretch of acidic and hydrophobic amino acids (579- 
585). Several actin-binding sites in other actin-binding pro- 
teins are positively charged interacting with acidic amino 
acids in actin (for reviews see Kabsch and Vandekerckhove, 
1992;  Vandekerckhove and Vancompernolle,  1992).  More 
data are required to localize exactly the amino acids in ezrin 
responsible for the actin binding. To understand the role of 
ezrin protein family in the dynamics of the cell surface struc- 
tures it will be important to determine the influence of ezrin 
and the other members of the protein family on the behavior 
of actin. 
Since experimental evidence for a direct interaction of ez- 
rin with actin has been difficult to obtain (Bretscher,  1983, 
1991; Krieg and Hunter,  1992),  it has been proposed that 
phosphorylation would be crucial for the interaction of ezrin 
with actin (Krieg and Hunter, 1992). Consequently, purified 
cellular ezrin would occur in a form where the actin-binding 
site  is  masked.  The  phosphorylation of tyrosine or  ser- 
ine/thrConine (Bretscher, 1989; Hanzel et al., 1991; Fazioli 
et al., 1993) could be a signal opening the actin-binding site 
in ezrin. Furthermore, it is possible that the affinity of the 
actin-binding site in ezrin is so weak that only the binding 
of filament actin to immobilized ezrin (and possibly not the 
binding of free ezrin to actin) can be seen in the actin-binding 
assay.  Stronger binding occurs presumably in the affinity 
chromatography when F-actin is bound to the GST-ezrin- 
Sepharose in several points of the filament. Monomeric actin 
could be lost during the washings in the case that it binds ez- 
rin weakly. In principle, several factors may contribute to the 
loss of actin binding of cellular ezrin during the purification. 
Evidence for a masked actin-binding site comes from the 
expression  of ezrin  cDNA  in  cultured cells.  Expression 
studies with full-length ezrin and COOH-terminal part of  ez- 
rin in cultured cells have indicated that the binding of ezrin 
to the cytoskeleton is dependent on the unmasking of the 
binding site in ezrin (Algrain et al., 1993). Both full-length 
ezrin and the COOH-terminal part of ezrin expressed from 
cDNA colocalized to microvilli and other cell surface struc- 
tures. However,  the full-length ezrin did not bind to stress 
fibers, whereas the COOH-terminal part of ezrin expressed 
in cells is seen to be colocalized with stress fibers in im- 
munofluorescence analysis (Algraln et al., 1993). This shows 
that the truncated ezrin missing the NH2-terminal  domain 
has  lost  its  physiological  regulation  of  the  binding  to 
cytoskeleton. The inability of full-length ezrin to bind to 
stress fibers indicates that the actin-binding site of ezrin must 
be unmasked by specific signals for the binding to actin to 
occur. 
The cloning of  phosphotyrosine phosphatases sharing over 
30% identity with the EzN domain gives indirect support for 
the phosphorylation as an essential regulatory signal in the 
function of ezrin protein family (Gu et al., 1991; Yang and 
Tonks,  1991). This is indicated also by experimental data. 
In A-431 human epidermoid carcinoma cells stimulated by 
EGF, the tyrosine and serine are transiently phosphorylated, 
concomitantly with the redistribution of ezrin to microvilli 
(Bretscher, 1989).  In gastric parietal cells the phosphoryla- 
tion of serine is increased when ezrin is induced to redistrib- 
ute to microvilli (Urushidani et al., 1989). More data on the 
structure-function relationship are required to understand 
how the phosphorylation regulates ezrin. Tyr-145 and Tyr- 
353 have been identified as the major tyrosine phosphoryla- 
tion sites of ezrin in the EGF stimulated A-431 cells (Krieg 
and Hunter, 1992). Another potential site for the regulation 
by tyrosine phosphorylation is  the conserved Tyr-564  in 
KYKXL motif  of  the actin-binding site in ezrin. One theoret- 
ical mechanism for tyrosine or serine/threonine phosphory- 
lation to regulate actin-binding would be by an influence on 
the dimerization of ezrin (Ullrich et al., 1986; Pakkanen and 
Vaheri,  1989;  Gary and Bretscher,  1993). 
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